The Asian Scientist 100
Lu Ke
Institution
Chinese Academy of Sciences
Country
China
Field
Materials Sciences
Lu is the winner of the 2020 Future Science Prize (Physical Science Prize) for discovering and synthesizing a superior nanotwinned structure and gradient nanostructure.
(Photo: Future Science Prize)
AWARDS
- Future Science Prize 2020
Related articles
Ulcer-Causing Helicobacter Pylori Survives In Our Acidic Gut By Turning It Neutral
Researchers at CUHK are slowly creating a blueprint to understand how the H. pylori pathogen stays alive and well in the acidic guts of half the world's population.
The Self-Made Eye: Formation Of Optic Cup From Stem Cells
A new report describes how mouse embryonic stem cells (ESCs) are able to differentiate and assemble into an optic cup of the eye.
Study: Six Genetic Variants Linked To Type 2 Diabetes In South Asians
A team of international researchers examined the genomic DNA of South Asian patients with type 2 diabetes, identifying six genetic variants associated with the disease.
Takeda’s TAK-385 In Phase II Trials For Endometriosis, Uterine Fibroids
Takeda Pharma announced today that it has initiated Phase II clinical trials of TAK-385 in Japan for the treatment of endometriosis and uterine fibroids.
Researchers Trace Cholera Pandemic Source To The Bay Of Bengal
Scientists studying the past 40 years of transmissions of cholera have found that the Bay of Bengal in India acts as a reservoir for cholera, where it can thrive and spread.
Bacteria In Panda Poop Used To Make Biofuels From Cellulose
Scientists say that panda poop contains bacteria that can be used to break down plant material to produce biofuels from grass, wood chips, and crop wastes.
Scientists Use Ultrafast Microexplosions To Create Super-Dense Aluminium
Researchers have created a new, super-dense version of aluminium that could lead to efficient production of new super-hard nanomaterials at a relatively low cost.
CUHK Study: Ketamine Abuse In Young Reduces Bladder Capacity
Researchers have found that the majority of young people with history of ketamine abuse have a reduced bladder capacity of up to 37 percent.
D-Pharm Gets South Korean Approval For Phase III Study Of Neuro Drug
D-Pharm Ltd. announced this week that the KFDA has approved the IND application for the Phase III MACSI study of DP-b99 in Korea.